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Introduction: Surgical treatment of ureteral endometriosis is necessary to relieve urinary
symptoms of obstruction and to preserve renal function. Which surgical approach to
ureteral endometriosis should be considered the most appropriate is debated, due to the
lack of scientific evidence. The aim of the present study is to assess the feasibility and
to describe the perioperative outcomes of minimally invasive treatment of deep ureteral
endometriosis using robotic assistance, highlighting the technical benefits and the limits
of this approach.
Method: A case-series including 31 consecutive patients affected by high-stage
endometriosis including ureteral endometriosis using robotic assistance in our
Department between November 2011 and September 2017.
Results: All procedures were successfully completed by robotic technique, resulting
in full excision of the parametrial nodules involving the ureter. Mean operating time was
184.8 ± 81min. Mean hospital stay was 4.02 ± 3 days. Perioperative complications
occurred in five patients and 4 out of 5 involved the urinary tract.
Conclusions: Robotic surgery for deep infiltrating endometriosis of the ureter was
feasible and allowed complete resection of ureteral nodules in all cases. No intraoperative
complications arose, but a non-negligible rate of urinary tract complications was
detected. This calls for a careful assessment of the benefits and specific risks associated
with the use of robotic surgery for the treatment of deep infiltrating endometriosis of the
ureter.
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INTRODUCTION
Deep-infiltrating endometriosis (DIE) affects about 20% of patients with endometriosis. Its clinical
behavior is extremely heterogeneous ranging from an asymptomatic finding to a severe disorder
involving multiple extragenital organs and causing symptoms as infertility, deep dyspareunia or
chronic pelvic pain in 50% of cases (1). DIE negatively impacts the physical status of patients,
their psychological and social quality of life (2). The urinary tract is involved in approximately
0.3–12% of patients with endometriosis, thus representing one of the most common extra-genital
system affected. The bladder is the most common location involved in about 80% of cases while
ureteral endometriosis is present in 14% of cases. Ureteral endometriosis is frequently classified as
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extrinsic or intrinsic according to histologic results and it is
usually unilateral. Extrinsic ureteral endometriosis is the most
usual finding, occurring in 80% of cases. It is characterized
by the infiltration of the peritoneum, the uterosacral ligament,
the ureteral adventitia and the surrounding connective tissue,
determining extrinsic compression of the ureteral wall due
to fibrosis and the related peri-ureteral desmoplastic reaction.
Intrinsic ureteral endometriosis is less common and involves the
mucosa or muscolaris propria (3–8).
Clinical presentation of ureteral lesions is various, and it
relates to the location and size of the endometriotic lesion.
A correct diagnosis is crucial because frequently few or even
no symptoms can attend this disease with possible silent
complications such as different degrees of hydronephrosis up
to the loss of renal function. Hence, patients may experience
non-specific abdominal pain, with 50% of patients lacking
urinary symptoms at the time of clinical assessment. To
identify ureteral endometriosis a broad variety of imaging
techniques, such as magnetic resonance, ultrasound, computed
tomography scan and intravenous retrograde pyelography have
been suggested. However, diagnosis of ureteral endometriosis is
still challenging and often a definitive assessment can be achieved
only laparoscopically and histologically (9–11).
Surgery is most often necessary to treat ureteral
endometriosis, with a variety of treatment options based
on the size and location of the lesion and with the general aim
to isolate and free the ureter from the endometriotic nodules.
This is needed in order to address urinary obstruction and to
preserve renal function (3). In the last 20 years, a broad body of
literature confirms that ureterolysis can be adequately achieved
by laparoscopic approach with acceptable complications rates
(ranging from 0 to 31%) and low risk of recurrences (ranging
from 0 to 12%). However, these results largely depend on
the operator’s dexterity and experience together with the size,
depth, and extension of ureteral endometriosis. Consequently,
which mini-invasive approach provides the best technical
aid to the surgeon still represents a matter of debate (3, 12–
14). This is particularly timely given the broad diffusion of
robotic-assisted mini-invasive surgery in gynecology. Indeed,
it could be predicted that any platform that provides a better
visualization and increases manual dexterity may come handy in
the surgical management of a difficult surgery such as that for
ureteral endometriosis. However, no such evidence exists in the
literature.
The purpose of the present report was to describe the
feasibility, safety, technical implications and perioperative
outcomes of excisional surgery for ureteral endometriosis using
robotic-assisted mini-invasive surgery with different da Vinci
platforms.
MATERIALS AND METHODS
Patients Selection and Clinical Assessment
The present study is a retrospective review of 31 consecutive
patients who underwent robotic-assisted laparoscopic excision
of endometriosis with ureteral involvement from November
2011 to September 2017. Patients were identified using ICD-9
selecting code of robotic-assisted endometriosis. All patients
with intraoperative visualization and histological confirmation
of Deep Infiltrating Endometriosis (DIE), who underwent
robotic-assisted laparoscopic endometriosis with ureteral
involvement using the da Vinci robotic platforms were included
in the study. Exclusion criteria were treatment by traditional
laparoscopy or abdominal route. Patients demographics
such as age, parity, body mass index (BMI) and American
Society of Anesthesiologists score (ASA) were derived from
detailed electronic chart review. Electronic patient’s files
yielded information on fertility, past surgical history, previous
hormonal treatments, preoperative examinations, and presence
of symptoms at admission. Operating time, amount of blood
loss, intraoperative complications and other relevant info related
to the surgical procedures were recorded. Post-operative items
such as length of hospitalization, recovery of urinary and bowel
function were noted. Related perioperative (within 7 days after
surgery), early post-operative (from 7 to 28 days after surgery),
and late post-operative (>28 days after surgery) complications
were evaluated according to the Clavien-Dindo classification
criteria (15).
All patients were enrolled in the endometriosis center of
our hospital, where a comprehensive clinical history is collected
during clinical assessment of the disease. The charts include
data concerning patient symptoms, including dysmenorrhea,
dyspareunia, dyschezia, dysuria, constipation or diarrhea,
chronic or peri-menstrual rectal or urological bleeding and
infertility.
The severity of symptoms was evaluated on a 10-point visual
analog scale (VAS), with a value of 10 as the worst pain suffered
and one corresponding to minimal pain perceived.
Current and past hormonal or non-hormonal therapies were
noted. In patients taking hormonal therapy in preparation for
surgery such as estroprogestin oral, vaginal or patch compounds,
progestins only or GnRH analogs the type and duration of
therapy was documented.
An accurate vaginal clinical examination was performed
in order to evaluate deep pelvic tissues involvement. If DIE
was strongly suspected, a rectal examination is performed
for the assessment of the disease and the planning of
further instrumental investigations. During the collection of
an exhaustive history of endometriosis and related symptoms,
we paid particular attention to urinary symptoms. Bilateral
Giordano maneuvers were carried out to induce or worsen pain
in latent renal dilatation. All patients underwent preoperative
transvaginal and transabdominal ultrasound assessment by
skilled operators to preoperatively assess the disease and its
related anatomical disruption.
When ureteral involvement was suspected, a full evaluation of
the urinary tract was performed, in the search of signs of ureteral
dilatation or hydronephrosis. In all such cases the urinary system
was also assessed with multislice computed tomography scans
or, alternatively, abdominal magnetic resonance imaging both
with intravenous injection of contrast medium and late-phase
acquisitions to investigate the whole urinary tract, to rule out
renal or ureteral dilatation. Hydronephrosis was defined as
any degree of the renal calyx or pelvis dilatation. In order
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to evaluate the degree of urterohydronephrosis, intravenous
pyelography was frequently performed and kidney scintigraphy
was also performed to assess renal function in presence of cortical
atrophy. In some cases of patients with ureterohydronephrosis
or in patients with assumed complex surgery or risks factors
the surgeon chose to proceed to preoperative ureteral stenting.
Cystoscopy was also performed in the case of suspected bladder
localization (9, 13, 14, 16–21). Detection of serum level of
creatinine before and after surgery was done in all patients.
All patients were preoperatively admitted in the Department
of Obstetrics and Gynecology of S. Chiara University Hospital
of Pisa for endometriosis assessment and preoperative clinic
evaluations. Surgery was performed in the operating rooms of
the Multidisciplinary Center of Robotic Surgery of Cisanello
University Hospital of Pisa using da Vinci Si and Xi robotic
systems (Intuitive Surgical Inc., Sunnyvale, CA, USA). All the
patients received surgery by gynecologic surgeons trained in
advanced mini-invasive techniques with high expertise and skills
in robotic approach. Severity and stage of endometriosis were
determined during surgery using the revised American Fertility
Society (rAFS) score system (22). The choice to use the robotic
platform to perform the procedure was left to the surgeons, based
on their experience. All patients enrolled for surgery had an
extensive preoperative counseling about the risks and benefits of
surgery for deep pelvic endometriosis signed a written informed
consent.
All patients were examined 3 months and 6 months
post-operatively, and yearly thereafter by the same group of
physicians. The institutional review board of the University of
Pisa approval was obtained for this study.
Surgical Preparation and Technique
All patients received mechanical bowel preparation and a single
dose of prophylactic antibiotic (Cefuroxime 1 g) 1 h before
skin incision; antithrombotic prophylaxis was administered, if
required, with low-molecular-weight heparin 12 h before surgery.
A Foley catheter was placed before beginning of surgery and
removed the day after. Surgery was performed using both da
Vinci Si and Xi surgical systems. After general anesthesia was
given, the patient was placed in a modified dorsolithotomic
position, with a 26◦ Trendelenburg position during the
procedure. The Veress needle was inserted at the umbilical
level to insuﬄate the abdomen. After pneumoperitoneum was
obtained, a umbilical 12 or 8mm (depending on robotic
platform) incision was made and the trocar was placed through
the umbilical incision and two other 8-mm lateral ports were
placed under direct visualization. A 10-mm assistant port was
also inserted. Pneumoperitoneum was kept at 8–12 mmHg.
The robotic surgical system was docked using three arms and
single-docking full robotic technique: camera port through the
umbilical incision and two robotic instrument ports through
the lateral incisions. A uterine manipulator was positioned to
manipulate the uterus from below. Robotic tools used during the
procedure included monopolar scissors, Maryland or fenestrated
bipolar forceps, a large needle holder, and a mega suture cut
needle holder if sutures were required. After induction of
pneumoperitoneum and insertion of the 30◦ robotic camera, the
whole abdominal cavity was explored. First, adhesions limiting
access to the pelvis were removed. Isolation of the involved ureter
was performed in all patients with DIE in order to approach safely
every pelvic localization of the disease, such as lateral and/or
posterior parametrium nodules. Lysis of adhesions allowed
surgeons to achieve full access to the pelvis, to free the ovaries and
to fix them to the abdominal wall with simple sutures or using
dedicated devices to gain proper visualization of the surgical field.
Nerve visualization began with the identification of the ureters at
their cross with the common iliac artery. In case of endometriosis
around the ureter, the opening of the retroperitoneum, starting at
a distance of 1–2 cmmedially from this cross allowed obtaining a
good exposure of the space. The pararectal space was developed
by peeling apart the leaf of the broad ligament, making a small
opening in the characteristic areolar tissue at the basis of the
broad ligament, and performing a gentle dissection with robotic
bipolar forceps and monopolar scissors into the pararectal space
so that the Latzko and Okabayashi spaces were laid open.
In detail, when the ureter was extrinsically involved by an
endometriotic lesion of the parametrium, in order to achieve
surgical radicality, the medial and the lateral pararectal space,
(Okabayashi’s and Latzko’s pararectal space) were developed
from the peritoneum of the sacral promontory to the lateral
parametrium predominantly using robotic bipolar forceps as
a dissector. Starting from the pelvic brim, ureterolysis was
performed along the course of the ureter on the pelvic sidewall
until healthy tissue was reached. This surgical task allowed ideal
identification of the hypogastric and uterine vessels, isolation
of the hypogastric nerves (HN) from the pelvic brim to the
pelvic plexus, detachment of the ureter, and identification of the
deep uterine vein that represents an anatomic-surgical landmark
useful for the identification of the plane which divides, ventrally
and cranially, the parametrial vascular portion from the neural
part, dorsally and caudally.
When lateral parametrium was involved, the ureter was
isolated up to its cross over the uterine artery, thus obtaining a
parametrial tunnel. The uterine artery was spared during these
operative steps; this was often feasible, with the exception of
those cases with a broad involvement of the cardinal ligament.
After this surgical step, medial visualization of the lateral part
of the superior hypogastric plexus (SHP) and the HN followed.
Identification of the HN at the origin allowed a conservative
approach during radical excision of endometriosis of the visceral
afferent and efferent nerves to the bladder, uterus, vagina, and
dorsally to the rectum. In order to preserve these fibers, they
were separated from the uterosacral ligaments, which were then
cut when necessary. All endometriotic nodules, including lesions
involving the uterosacral ligaments, peritoneum, the torus of the
uterus and vagina were excised.
In conclusion, in the case of extrinsic ureteral endometriosis
ureterolysis could be accomplished using bipolar forceps and
monopolar scissors until all anatomic structures were completely
free from disease. During all procedures, care was taken to
minimize the risk of ureteral resection. When skeletonization
was concluded an accurate check of the whole pelvic ureter
was performed to identify intraoperative lesions. If a ureteral
lesion was detected or strongly suspected in a patient who
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didn’t undergo preoperative ureteral stenting, a stent was placed
intraoperatively by cystoscopy at the end of robotic treatment
and then removed after 60 days in order to decrease the risk
of fistula. In the case of an intraoperative ureteral injury the
surgeon extemporarily decided whether to perform a robotic
suture or to perform a ureteral resection with re-anastomosis.
This surgical choice depended also on whether the endometriotic
nodule involved intrinsically the mucosa or muscolaris. In this
series of robotic procedures, all additional pelvic endometriotic
lesions were removed during the same surgery (Figure 1A–D).
Statistical Analysis
Sample characteristics were determined using descriptive
statistics. Continuous variables were expressed as the mean,
median and range, whereas categorical variables were expressed
as counts and percentages. The statistical package SPSS R©,
version 17 (Windows, SPSS Inc., Chicago, Il USA) were used for
data analysis.
RESULTS
From November 2011 to September 2017, 31 patients with
high-stage pelvic endometriosis including ureteral involvement
underwent robotic-assisted surgery. Surgeries were performed
by three different surgeons (TS, AP, VC) with advanced
skills in robotic surgery. The patients had a mean age of
39.1 ± 4.5 years and mean Body Mass Index (BMI) of
23 ± 2.6 Kg/m2. Twelve patients (21.7%) had undergone
previous surgery for endometriosis. Twenty-one patients (67.7%)
complained of dysmenorrhea, 20 (64.5%) of dyspareunia, 13
(41.9%) of urinary tract symptoms (dysuria and hydronephrosis,
hydroureteronephrosis) and 8 (12.9%) of bowel symptoms.
Ureteral stenting before surgery was performed in 9 patients
(29%). At the time of surgery 20 patients (64.5%) took
hormonal therapy (estroprogestins, progestin-only pills, and
GnRH analogs). The characteristics of the patients are reported
in Table 1.
Mean operating time was 184.8 ± 81min (range 70–330min)
and estimated blood loss 207 ± 142ml (range 35–430ml). None
of the patients required an intraoperative blood transfusion.
In 28 cases (90.3%) surgeons preferred three robotic arms
whereas in 3 (9.7%) cases the fourth arm was used. Surgeons
chose side docking in 29 cases (93.5%) and central docking in
2 cases (6.5%). Right side docking was preferred in 22 cases
of 29 (75.8%) whereas left side docking in 7 cases (24.2%).
Robotic ureterolysis was associated in 6 cases (19.3%) to a recto-
vaginal nodule resection, in 24 cases (77.4%) to resection of the
uterosacral ligament and in 7 cases (22.6%) to excision of ovarian
FIGURE 1 | Different steps of surgical excision of endometriotic nodule involving the ureter. (A) Opening of the broad ligament and identification of the right ureter
involved by an extrinsic lesion. (B) In case of extrinsic ureteral endometriosis, ureterolysis is accomplished using bipolar forceps and monopolar scissors until
anatomical structures seem completely free from disease. (C) During the procedure, care is taken to minimize the risk of ureteral resection and injuries to surrounding
structures, with a particular attention to preserving the nerves. (D) When skeletonization is concluded an accurate check of the whole pelvic ureter is performed to
identify intraoperative lesions.
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TABLE 1 | Patients characteristics.
n (%)
N. of case 31
Age (years ± SD) 39.1 ± 4.56
BMI (kg/m² ± SD) 22.97 (21.75%)
History of endometriosis surgery 12 (38.7%)
PARITY
Nulliparus 20 (64.5%)
Primiparus or multiparus 11 (35.4%)
SYMPTOMS
Dysmenorrhea 21 (67.7%)
Dyspareunia 20 (64.5%)
Urinary tract signs 13 (41.9%)
Digestive signs 8 (25.8%)
ASA SCORE
I 2 (6.4%)
II 25 (80.6%)
III 4 (12.9%)
IV 0
Perioperative hormonal
treatment
20 (64.5%)
Preoperative stenting 9 (29%)
ASA, American Society of Anesthesiologists.
endometriomas. In 21 cases the endometriotic nodule involved
the left ureter while in 10 cases the right ureter was involved.
Ureterolysis was successfully completed in all cases. In all
cases, the resection of the endometriotic nodule surrounding
or involving the ureter was considered to be complete, with no
residual endometriotic tissue.
Five patients (16%) reported immediate intraoperative or
post-operative complications; four out of five involved the
urinary tract. Ureteral injury occurred in one patient, requiring
robotic ureterovesical reimplantation after intraoperative
stenting (during the same surgery). During surgery for
concomitant ureteral and uterosacral endometriosis one ureteral
fistula occurred after a ureteral injury during shaving of the
nodule from the ureteral wall. The patients had not received
preoperative ureteral stenting. In this case a second operation
was performed to repair the fistula. One patient developed a
paravaginal hematoma treated conservatively with antibiotic
prophylaxis. No complications related to the duration and
the steepness of the Trendelenburg position neither to robotic
trocars or instruments occurred during all procedures. Total
reoperation rate was 6.4% (n = 2). The average length of stay
was 4 days. Histopathology reports confirmed the presence of
endometriotic tissue in all cases (Table 2).
DISCUSSION
Our experience using the robotic approach to ureteral
endometriosis shows that the procedure is feasible, extremely
reproducible and safe with rates of complications that are
in line with the literature. All procedures were completely
TABLE 2 | Perioperative results.
Patients n 31 (%)
Operating time (min) 184.8 ± 81
Estimated blood loss 207 ± 142
Hospital stay (days) 4.02 ± 3
Full robotic technique 31 (100%)
ROBOTIC ARMS
Three arms 28 (90.3%)
Four arms 3 (9.7%)
Side Docking 29 (93.5%)
Right side 22 (75.8%)
Left side 7 (24.2%)
Central docking 2 (6.5%)
ASSOCIATED SURGERY
Rectovaginal nodules 6 (19.3%)
Uterosacral ligaments 24 (77.4%)
Endometriomas 7 (22.6%)
URETERAL ENDOMETRIOSIS
Left 21 (67.7%)
Right 10 (32.3%)
MAIN COMPLICATIONS
Ureteral fistula 2 (6.4%)
Hydronephrosis 1 (3.2%)
Vaginal hematoma 1 (3.2%)
Ureterovescical reimplantation 1 (3.2%)
Histopathology confirmation 31 (100%)
performed by robotic technique, notwithstanding the complexity
of the surgical procedures, involving patients with high rates
of previous surgery and multicompartmental, high-stage
endometriosis. In our series, 38.7% of patients who underwent
robotic treatment had a previous history of endometriosis
surgery and 41.9% of patients claimed urinary tract symptoms
before surgery. Moreover, a consistent proportion of our
population (64.5%) was receiving perioperative hormonal
treatment at the time of surgery with no significant improvement
of symptoms. Indeed, in our series, robotic ureterolysis was
associated in 6 cases (19.3%) to recto-vaginal nodule resection,
in 24 cases (77.4%) to resection of the uterosacral ligament
and in 7 cases (22.6%) to excision of ovarian endometriomas.
This highlights the fact that our population is representative
of the typical clinical scenario of a chronic or recurrent
disease often with previous surgical procedures that is
the common presentation of the patient with DIE of the
ureter.
It well-appreciated how ureteral endometriosis (and more
in general DIE) is challenging from a surgical standpoint. An
extensive knowledge of anatomy and of its variability, as well
as appropriate surgical skills are mandatory to approach this
disease. This is even more relevant due to the fact that the
improvement of symptoms is closely related to the radicality of
the surgical excision of the endometriotic nodules. Thus, any tool
that may facilitate safe and effective dissection of DIE is possibly
important to improve the success of the procedures.
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The da Vinci robotic surgical platform (Intuitive Surgical
Inc., Sunnyvale, CA, USA) may be a rational step forward to
achieve a safe and radical minimally invasive surgery for ureteral
endometriosis. The robotic platform has recently changed
laparoscopy, adding increased magnification with its 10X
view/three-dimensional vision, 7◦ of freedom of the instruments,
and physiologic tremor filtering. These peculiarities provide
surgeons with an improved ergonomic setting, simplifying
complex laparoscopic steps in the narrow operative field of the
pelvis such as suturing or performing dissection, thus facilitating
anatomical identification and preservation of critical structures
without compromising the radicality of surgery (23–25).
Relevant to this point of view, in all our cases a complete
excision of the parametrial nodule involving the ureter was
achieved, with no residual disease left. This may highlight how
the robotic platform may be useful to achieve those complex
dissections and surgical maneuvers that are requested to obtain
a complete isolation of the ureter and a satisfactory excision of
the parametrial nodules.
However, increased radicality often carries the inherent
risk of an increased complication rate, which is not desirable
in the face of the young age of the typical patient and
of the aim of surgery, which is always to improve quality
of life. Indeed, the distorted anatomy of the pelvis with
endometriosis and the technical limits of traditional laparoscopy
still make radical pelvic surgery extremely challenging with
rates of urogenital complications described for conventional
laparoscopy that compare to those of open surgery (19, 25–
27). In 2009 Bosev et al. published the largest series on
laparoscopic approach to ureteral endometriosis observing
1% of ureteral complications. Later series demonstrated that
in expert hands laparoscopic ureterolysis can be successfully
accomplished with a slight rate of perioperative complications
(10, 12, 14, 16, 21). Uccella et al. in 2014 showed even lower
rates (<1%) of intraoperative ureteral injuries and long-term
complications in a high-risk patients series, thus confirming
that with an adequate level of surgical expertise, ureteral
endometriosis can be effectively managed laparoscopically
(19).
At the same time, evidence reporting on whether the robotic
approach to ureteral DIE may be safer is weak and controversial
(27–29). Only one study published by Nezhat et al. compared
perioperative outcomes of conventional and robotic laparoscopic
treatment of endometriosis whatever the stage of disease in a
series of 78 patients. However, only 5% of the patients had
stage 4 endometriosis. The authors described no conversion
to laparotomy and similar outcomes for the two different
minimally invasive approaches with longer operating times in the
robotic group. The authors did not demonstrate any advantage
of robotic resection of early stages of endometriosis thus
recommending such surgery for stage 3 and 4 (25). Interestingly,
a recent international multicentric retrospective study by Collinet
evaluated perioperative outcomes of 164 women with stage 4
endometriosis who underwent robotic treatment. They described
one conversion to laparotomy, two bowel injuries and two
ureteral fistulae after ureterolysis with a reoperation rate of
1.8%. In addition, this is the only report on robotic surgery
for ureteral endometriosis evaluating reproductive outcomes.
After surgical treatment, 41.2% of women had a desire for
pregnancy, and 28.2% of them became pregnant (28). In
2011, the group of Brudie described the outcomes of a series
of 80 patients who underwent robotic surgery for stage 4
endometriosis but only in 36.3% of surgeries ureterolysis was
performed. This series reported shorter operating time, similar
re-operation rate but a significantly higher rate of conversion
to laparotomy (5%) compared with the multicentric report of
Collinet (29).
In our experience, two patients (6.4%) presented post-
operative ureteral fistula needing re-intervention; one (3.2%)
developed hydronephrosis and one patient (3.2%) underwent
ureterovesical re-implantation thus demonstrating that the rate
of complications is not negligible with this technique and should
be further explored.
In discussing why a surgical platform that allows better
view, enhanced dexterity and increased precision may still be
associated with urinary tract complications a set of items should
be taken in mind. From a technical standpoint, many surgeons
dislike the absence of tactile feedback during the initial use
of the robotic console, however, magnification of the images
thanks to the three-dimensional vision fills in this gap and
increases the precision of accurate dissection around delicate
anatomical structures such as the ureter, the rectum, the bladder
or nerves without compromising the identification and the
radical dissection of endometriotic nodules (28). This peculiar
way of compensating for tactile absence may be relevant to the
development of complications. The main surgical difficulty in
these procedures is the dissection of severe adhesions around
sensitive structures such as the ureter, the bladder, the rectum or
nerves. It is plausible to hypothesize that the two cases of ureteral
fistula and the lesion of ureter that required re-implantation may
have been facilitated by the lack of tactile feedback, possibly
allowing the surgeon to exert excessive strength during ureteral
shaving. In our series, preoperative stenting was performed
only in 9 (29%) patients. If lack of tactile accuracy represents
a pitfall, a possible counter-measure could be represented by
pre-surgical ureteral stenting in all women enrolled for robotic
treatment.
A second technical issue with robotic surgery for ureteral
DIE may possibly be represented by the extensive use of
energy to achieve dissection that is typical of robotic surgery.
To date, there is an absolute lack of literature concerning
the degree of lateral heat spread with robotic monopolar,
bipolar and ultrasonic tools. Only a paper by Lukas J.
et coll. demonstrates that coagulation instruments used in
robotic laparoscopic surgery have different thermal spreads
depending on power setting and application time, however,
the authors did not test the instruments in gynecologic
surgery (30).
The main weakness of our study, as with all the previously
published series, relates to the number of patients. In fact, we have
to acknowledge that the retrospective design and the modality of
the collection of outcomes do not allow obtaining information on
long-term and reproductive outcomes. Furthermore, this report
does not describe quality of life after surgery.
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Our study shows that robotic assistance allows complete,
radical, excision of ureteral endometriosis in complex cases.
Robotic surgery is safe in terms of intraoperative outcomes
but the rate of urinary tract complications is not negligible.
Careful attention should be dedicated in the coming years
to understand correctly the surgical differences of robotic-
assisted as compared to standard laparoscopy. This is particularly
relevant in terms of safety and complication rates that
may be modified specifically by the robotic platform, which
has an impact on surgical manipulations and mode of
energy use.
In conclusion, whether robotic assistance may improve the
outcomes of patient with ureteral DIE remains to be explored.
Nevertheless, our results show that robotic surgery is highly
effective in terms of radicality of excision of endometriotic
nodules involving the ureters, with non-negligible rates of post-
operative urinary tract complications.
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